Menlo Park, CA, United States of America

Felice Alessio Bava

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Felice Alessio Bava: Innovator in RNA Visualization Technology

Introduction

Felice Alessio Bava is a prominent inventor based in Menlo Park, CA. He has made significant contributions to the field of molecular biology, particularly in the visualization of RNA. With a total of 2 patents, Bava's work is at the forefront of innovative techniques for analyzing nucleic acids in single cells.

Latest Patents

Bava's latest patents include a groundbreaking method titled "Multiplexed single molecule RNA visualization with a two-probe proximity ligation system." This innovative approach, known as SNAIL, provides a cost-efficient means of detecting specific nucleic acids in single cells. The technology can be combined with flow cytometry, allowing for the simultaneous analysis of large numbers of cells for multiple nucleic acids. This method enables the analysis of anywhere from one to over twenty transcripts at a remarkable rate of up to 500 cells per second. The techniques require only two primers for amplification, which may also include a detection primer, enhancing the efficiency of the process.

Career Highlights

Felice Bava is affiliated with Leland Stanford Junior University, where he continues to advance research in molecular biology. His work has garnered attention for its potential applications in various fields, including diagnostics and therapeutic development.

Collaborations

Bava has collaborated with notable colleagues such as Nikolay Samusik and Yury Goltsev, contributing to the advancement of innovative research in RNA visualization.

Conclusion

Felice Alessio Bava's contributions to RNA visualization technology exemplify the impact of innovative research in molecular biology. His patents and collaborative efforts continue to pave the way for advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…